Breaking News Instant updates and real-time market news.

MYOV

Myovant Sciences

$22.42

-0.13 (-0.58%)

16:39
08/07/18
08/07
16:39
08/07/18
16:39

Myovant Sciences reports Q1 EPS (98c), consensus (85c)

MYOV Myovant Sciences
$22.42

-0.13 (-0.58%)

04/05/18
LEHM
04/05/18
NO CHANGE
LEHM
Barclays upgrades Merck, downgrades Biogen and Pfizer in sector reassessment
Barclays analyst Geoff Meacham made some rating changes while reassessing the Biopharmaceutical sector. Biopharma sentiment has been negative since the start of 2018, despite a modest pick-up in deals and diminished rhetoric on drug pricing, Meacham tells investors in a research note titled "U.S. Biopharmaceuticals: Where to from here?" The analyst believes "more transformative" acquisitions, "clean" Phase 3 wins, and even a relatively strong Q1 earnings season could help "re-rate the sector" and get investors more engaged in the group. Ahead of the Q1 earnings season, Meacham upgraded Merck (MRK) to Overweight from Equal Weight and downgraded to Equal Weight from Overweight shares of Biogen (BIIB), Pfizer (PFE), Biohaven Pharmaceutical (BHVN) and Myovant Sciences (MYOV). The analyst also lowered his price target for Equal Weight-rated AbbVie (ABBV) to $102 from $120, for Equal Weight-rated Amgen (AMGN) to $180 from $180, for Overweight-rated Prothena (PRTA) to $50 from $70 and for Overweight-rated Incyte (INCY) to $135 from $165.
04/05/18
04/05/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Intel (INTC) downgraded to Hold from Buy at Stifel with analyst Kevin Cassidy citing the peaking server central processing unit cycle and valuation for the downgrade. 2. Johnson Controls (JCI) downgraded to Underperform from Sector Perform at RBC Capital with analyst Deane Dray citing the company's exposure to additional cash flow pressures in fiscal 2018, reduction in fiscal 2020 targets, and a market rotation toward "more defensive names." 3. Ryder (R) downgraded to Underweight from Neutral at JPMorgan with analyst Brian Ossenbeck saying he is making a "longer term call on 2019 expectations," which he believes are too high and embed "significant gains on residual values and used truck sales." 4. Ollie's Bargain Outlet (OLLI) downgraded to Neutral from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying valuation is getting "richer," quarterly comps have been decelerating since 2015, and are now expected to be 1%-2% in 2018. 5. Biogen (BIIB), Pfizer (PFE), Biohaven (BHVN), and Myovant Sciences (MYOV) were downgraded to Equal Weight from Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/25/18
SBSH
04/25/18
NO CHANGE
Target $44
SBSH
Buy
Myovant Sciences price target raised to $44 from $17 at Citi
Citi analyst Robyn Karnauskas raised her price target for Myovant Sciences to $44 from $17 saying now is the time to own the shares. The analyst expects the initial Phase 3 endometriosis/uterine fibroids data expected in 12-18 months to be positive. She believes it is time to assign full credit to Relugolix in the U.S. for endometriosis/uterine fibroids. The analyst thinks the trials will be successful and is giving 100% probability in endometriosis and uterine fibroids in the U.S. and 50% in Europe as well as 50% credit in prostate cancer worldwide. Karnauskas keeps a Buy rating on Myovant.
07/24/18
SBSH
07/24/18
NO CHANGE
SBSH
Buy
Citi says Myovant may have $102 upside if relugolix priced at parity to elagolix
After AbbVie (ABBV) and Neurocrine Biosciences (NBIX) announced that the FDA approved elagolix and Neurocrine said the list price has been set at $28 per day, Citi analyst Robyn Karnauskas noted that she currently models Myovant Sciences' (MYOV) relugolix priced at $10 per day. Modeling relugolix pricing at parity to elagolix and assuming a gross-to-net of 100% would lead to a fair value estimate for Myovant of $146, or the equivalent of $102 of upside from her current price target of $44, Karnauskas stated. The analyst, who models a split market between relugolix and elagolix in endometriosis, keeps a Buy rating on Myovant shares.

TODAY'S FREE FLY STORIES

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

12:30
11/19/18
11/19
12:30
11/19/18
12:30
Periodicals
China's WTO envoy says China to propose WTO changes, Reuters says »

Zhang Xiangchen,…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$269.10

-4.65 (-1.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$30.41

0.11 (0.36%)

12:26
11/19/18
11/19
12:26
11/19/18
12:26
Periodicals
White House still seeking to take Jim Acosta's press pass away, WSJ says »

The White House is still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

PEP

PepsiCo

$118.30

-0.09 (-0.08%)

12:25
11/19/18
11/19
12:25
11/19/18
12:25
Options
PepsiCo call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 15

    Feb

AAL

American Airlines

$35.36

-1.38 (-3.76%)

12:22
11/19/18
11/19
12:22
11/19/18
12:22
Hot Stocks
APA seeks to open contract negotiations with American Airlines »

The Allied Pilots…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRLCY

L'Oreal

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Hot Stocks
L'Oreal appoints of Christophe Babule to succeed Christian Mulliez as CFO »

L'Oreal announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/19/18
11/19
12:17
11/19/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMX

Aevi Genomics Medicine

$1.12

-0.04 (-3.45%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Conference/Events
Aevi Genomics Medicine management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/19/18
11/19
12:16
11/19/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$21.82

-0.43 (-1.93%)

12:15
11/19/18
11/19
12:15
11/19/18
12:15
Options
Teva put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

PRT

PermRock Royalty Trust

$10.75

-1.3 (-10.79%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
PermRock Royalty Trust falls -10.9% »

PermRock Royalty Trust is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFX

Colfax

$23.54

-4.46 (-15.93%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Colfax falls -15.9% »

Colfax is down -15.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SPB

Spectrum Brands

$47.10

-12.26 (-20.65%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Spectrum Brands falls -20.7% »

Spectrum Brands is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ZAYO

Zayo Group

$25.98

2.285 (9.64%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Zayo Group rises 9.8% »

Zayo Group is up 9.8%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

REN

Resolute Energy

$34.93

4.42 (14.49%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
Resolute Energy rises 14.7% »

Resolute Energy is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$11.95

-0.115 (-0.95%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Options
35K US Oil Fund Jan 11 - 11.5 put spreads trade 16c on ISE »

35K US Oil Fund Jan 11 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$175.00

23 (15.13%)

12:00
11/19/18
11/19
12:00
11/19/18
12:00
Hot Stocks
VelocityShares 3x Long Natural Gas ETN rises 16.1% »

VelocityShares 3x Long…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$78.22

-1.45 (-1.82%)

, AMZN

Amazon.com

$1,541.22

-52.37 (-3.29%)

11:59
11/19/18
11/19
11:59
11/19/18
11:59
Earnings
Fly Intel: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$78.22

-1.45 (-1.82%)

AMZN

Amazon.com

$1,541.22

-52.37 (-3.29%)

WMT

Walmart

$97.07

-0.63 (-0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

WB

Weibo

$57.67

-1.6 (-2.70%)

11:55
11/19/18
11/19
11:55
11/19/18
11:55
Options
Weibo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

11:55
11/19/18
11/19
11:55
11/19/18
11:55
General news
More from Fed's Williams: U.S. employers are hiring less-skilled »

More from Fed's…

SNAP

Snap

$6.12

-0.37 (-5.70%)

, TWTR

Twitter

$32.44

-1.26 (-3.74%)

11:54
11/19/18
11/19
11:54
11/19/18
11:54
Conference/Events
FBN Securities social media/advertising analysts to hold group luncheon »

Analysts hold a Group…

SNAP

Snap

$6.12

-0.37 (-5.70%)

TWTR

Twitter

$32.44

-1.26 (-3.74%)

AMZN

Amazon.com

$1,539.71

-53.88 (-3.38%)

FB

Facebook

$132.94

-6.61 (-4.74%)

GOOG

Alphabet

$1,037.20

-24.81 (-2.34%)

IPG

Interpublic Group

$23.79

-0.26 (-1.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

  • 03

    Dec

  • 04

    Dec

  • 03

    Mar

11:52
11/19/18
11/19
11:52
11/19/18
11:52
Conference/Events
Stephens analyst to hold an analyst/industry conference call »

Analysts host weather…

AAPL

Apple

$186.58

-6.84 (-3.54%)

, FB

Facebook

$133.19

-6.36 (-4.56%)

11:51
11/19/18
11/19
11:51
11/19/18
11:51
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AAPL

Apple

$186.58

-6.84 (-3.54%)

FB

Facebook

$133.19

-6.36 (-4.56%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$35.00

4.49 (14.72%)

XEC

Cimarex Energy

$88.90

0.27 (0.30%)

NIO

NIO Inc.

$8.08

0.9 (12.53%)

CFX

Colfax

$23.67

-4.33 (-15.46%)

BX

Blackstone

$31.87

-0.61 (-1.88%)

SPB

Spectrum Brands

$47.25

-12.11 (-20.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

11:47
11/19/18
11/19
11:47
11/19/18
11:47
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

CLF

Cleveland-Cliffs

$10.05

-0.25 (-2.43%)

11:45
11/19/18
11/19
11:45
11/19/18
11:45
Options
Cleveland-Cliffs call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:44
11/19/18
11/19
11:44
11/19/18
11:44
Conference/Events
RBC Capital healthcare services analyst to hold a group luncheon »

Group Luncheon, where…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.